Cargando…
Optimum population-level use of artemisinin combination therapies: a modelling study
BACKGROUND: Artemisinin combination therapies (ACTs) are used worldwide as first-line treatment against confirmed or suspected Plasmodium falciparum malaria. Despite the success of ACTs at reducing the global burden of malaria, emerging resistance to artemisinin threatens these gains. Countering ons...
Autores principales: | Nguyen, Tran Dang, Olliaro, Piero, Dondorp, Arjen M, Baird, J Kevin, Lam, Ha Minh, Farrar, Jeremy, Thwaites, Guy E, White, Nicholas J, Boni, Maciej F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641185/ https://www.ncbi.nlm.nih.gov/pubmed/26545449 http://dx.doi.org/10.1016/S2214-109X(15)00162-X |
Ejemplares similares
-
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023) -
Artemisinin resistance – modelling the potential human and economic costs
por: Lubell, Yoel, et al.
Publicado: (2014) -
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
por: Watson, Oliver J, et al.
Publicado: (2022) -
Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)